Drugs / GI001
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07584850 | Apr → Jul 2026 overdue | B-cell non-Hodgkin lymphoma | Ruijin Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GI001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07584850 ↗ |